infectious diseases

News

BiomX reports “impressive” data in first bacteriophage trial

Hope that bacteriophages could represent a new therapeutic strategy for resistant bacterial infections has been bolstered by a study conducted by BiomX in cystic fibrosis

News

Valneva eyes first place in chikungunya vaccine race

Valneva has moved a step closer to its goal of becoming the first company to file for approval of a vaccine against chikungunya virus in the US after reporting new clinical data today.

News

Sanofi invests in French vaccines facility

Sanofi is to invest 170 million euros to expand a manufacturing facility in France, suggesting the company is confident in the prospects for its vaccines business at a time when its flagshi

Partner Content